$11.38
0.010.09%
At Close: -
$11.38
00.00%
After Hours: 1:01 PM EDT
15 minutes delayed
Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics | -$0.14 | -$0.12 | — | — | $20.75M | $23.43M | — | — | 08/08/2024 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.15 | -$0.14 | -$0.15 | -7.14% | $20.25M | $22.22M | $19.93M | -10.30% | 05/07/2024 | Get Alert |
YMAB | Y-mAbs Therapeutics | $0.03 | -$0.20 | -$0.02 | 90.00% | $31.45M | $20.95M | $23.36M | 11.52% | 02/29/2024 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.63 | -$0.19 | -$0.18 | 5.26% | $12.54M | $20.93M | $20.45M | -2.27% | 11/13/2023 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.94 | -$0.24 | -$0.14 | 41.67% | $10.80M | $20.35M | $20.75M | 1.97% | 08/10/2023 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.64 | -$0.32 | -$0.15 | 53.12% | $10.49M | $15.55M | $20.25M | 30.23% | 05/08/2023 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.85 | -$0.46 | $0.03 | 106.52% | $9.60M | $20.06M | $31.45M | 56.76% | 03/30/2023 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.66 | -$0.71 | -$0.63 | 11.27% | $8.96M | $12.01M | $12.54M | 4.39% | 11/07/2022 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.53 | -$0.69 | -$0.94 | -36.23% | $10.95M | $11.22M | $10.80M | -3.77% | 08/08/2022 | Get Alert |
YMAB | Y-mAbs Therapeutics | $0.75 | -$0.72 | -$0.64 | 11.11% | $5.38M | $10.90M | $10.49M | -3.80% | 05/09/2022 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.48 | -$0.70 | -$0.85 | -21.43% | $20.75M | $10.82M | $9.60M | -11.29% | 02/24/2022 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.82 | -$0.60 | -$0.66 | -10.00% | $0.00 | $10.87M | $8.96M | -17.53% | 11/04/2021 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$1.01 | -$0.64 | -$0.53 | 17.19% | $0.00 | $7.85M | $10.95M | 39.50% | 08/05/2021 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.66 | $0.19 | $0.75 | 294.74% | $0.00 | $44.47M | $5.38M | -87.90% | 05/06/2021 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.61 | -$0.51 | -$0.48 | 5.88% | $0.00 | $15.54M | $20.75M | 33.53% | 02/25/2021 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.70 | -$0.79 | -$0.82 | -3.80% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.53 | -$0.68 | -$1.01 | -48.53% | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.47 | -$0.62 | -$0.66 | -6.45% | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.42 | -$0.67 | -$0.61 | 8.96% | $0.00 | — | $0.00 | — | 03/12/2020 | Get Alert |
YMAB | Y-mAbs Therapeutics | -$0.42 | -$0.55 | -$0.70 | -27.27% | $0.00 | — | $0.00 | — | 11/13/2019 | Get Alert |
YMAB | Y-mAbs Therapeutics | — | -$0.49 | -$0.53 | -8.16% | — | — | $0.00 | — | 08/14/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $-0.15 | $-0.14 | -7.14 % |
Dec 2023 | 2024-02-29 | $-0.02 | $-0.20 | 90.0 % |
Sep 2023 | 2023-11-13 | $-0.18 | $-0.19 | 5.26 % |
Jun 2023 | 2023-08-10 | $-0.14 | $-0.24 | 41.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $19.93M | $22.22M | -10.3 % |
Dec 2023 | 2024-02-29 | $23.36M | $20.95M | 11.5 % |
Sep 2023 | 2023-11-13 | $20.45M | $20.93M | -2.27 % |
Jun 2023 | 2023-08-10 | $20.75M | $20.35M | 1.97 % |
Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $-0.15, which missed the estimate of $-0.14.
The Actual Revenue was $19.9M, which missed the estimate of $22.2M.
Browse earnings estimates, EPS, and revenue on all stocks.